Leukocytapheresis for ulcerative colitis: A comparative study of anticoagulant (nafamostat mesilate vs. dalteparin sodium) for reducing clinical complications

Therapeutic Apheresis and Dialysis

Volumn 10, Issue 1, 2006, Pages 54-58

  Ashizuka, Shinya ^a   Nishiura, Ryosuke ^a   Ishikawa, Naoto ^b   Yamaga, Junichi ^a   Inatsu, Haruhiko ^a   Fujimoto, Shouichi ^a   Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b Ishikawa Clinic   (Japan)

Author keywords

Complications; Dalteparin sodium; Leukocytapheresis; Nafamostat mesilate; Ulcerative colitis

Indexed keywords

DALTEPARIN; NAFAMSTAT MESILATE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DYSPNEA; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HEART PALPITATION; HUMAN; HYPOTENSION; IMMUNOMODULATION; LEUKOCYTE DIFFERENTIAL COUNT; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RASH; THORAX PAIN; ULCERATIVE COLITIS; URTICARIA; VOMITING;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; COLITIS, ULCERATIVE; DALTEPARIN; FEMALE; GUANIDINES; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33644990109     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2006.00309.x     Document Type: Article

References (24)

1. Podolsky DK Inflammatory bowel disease N Engl J Med 2002 347 417 29
2. Fiocchi C Inflammatory bowel disease: etiology and pathogenesis Gastroenterology 1998 115 182 205
3. Jewell DP Snook JA Immunology of ulcerative colitis and Crohn's disease In Allan RN Keighler MR Alexander-Williams J Hawkins C eds Inflammatory Bowel Disease London Churchill Livingstone 1990 127 46
4. Sawada K Muto T Shimoyama T et al. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column Curr Pharm Des 2003 9 307 21
5. Shirokaze J Leukocytapheresis using a leukocyte removal filter Ther Apher 2002 6 261 6
6. Sawada K Ohnishi K Fukui S et al. Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease J Gastroenterol 1995 30 322 9
7. Shibata H Kuriyama T Yamawaki N Cellsorba Ther Apher Dial 2003 7 44 7
8. Ayabe T Ashida T Taniguchi M et al. A pilot study of centrifugal leukocyte apheresis for corticosteroid - resistant active ulcerative colitis Intern Med 1997 36 322 6
9. Sasaki M Tsujikawa T Fujiyama Y Bamba T Leukocytapheresis therapy for severe ulcerative colitis Ther Apher 1998 2 101 4
10. Sawada K Ohnishi K Kosaka T et al. Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis Ther Apher 1997 1 207 11
11. Akizawa T Koshikawa S Ota K Kazama M Mimura N Hirasawa Y Nafamostat mesilate: a regional anticoagulant for hemodialysis in patients at high risk for bleeding Nephron 1993 64 376 81
12. Nagase K Sawada K Ohnishi K Egashira A Ohkusu K Shimoyama T Complications of leukocytapheresis Ther Apher 1998 2 120 4
13. Nagase K Fukunaga K Ohnishi K Kusaka T Matoba Y Sawada K Detection of specific IgE antibodies to nafamostat mesilate as an indication of possible adverse effects of leukocytapheresis using nafamostat mesilate as anticoagulant Ther Apher Dial 2004 8 45 51
14. Yamazato M Mano R Oshiro-Chinen S et al. Severe abdominal pain associated with allergic reaction to nafamostat mesilate in a chronic hemodialysis patient Intern Med 2002 41 864 6
15. Higuchi N Yamazaki H Kikuchi H Gejyo F Anaphylactoid reaction induced by a protease inhibitor, nafamostat mesilate, following nine administrations in a hemodialysis patient Nephron 2000 86 400 1
16. Maruyama H Miyakawa Y Gejyo F Arakawa M Anaphylactoid reaction induced by nafamostat mesilate in a hemodialysis patient Nephron 1996 74 468 9
17. Seo M Okada M Yao T Ueki M Arima S Okumura M An index of disease activity in patients with ulcerative colitis Am J Gastroenterol 1992 87 971 6
18. Ross AS Cohen RD Medical therapy for ulcerative colitis: the state of the art and beyond Curr Gastroenterol Rep 2004 6 488 95
19. Hanauer SB Medical therapy for ulcerative colitis 2004 Gastroenterology 2004 126 1582 92
20. Xu CT Meng SY Pan BR Drug therapy for ulcerative colitis World J Gastroenterol 2004 10 2311 17
21. Opatrny K Jr. Clinical importance of biocompatibility and its effect on haemodialysis treatment Nephrol Dial Transplant 2003 18 Suppl v41 4
22. Schaefer RM Schaefer L Horl WH Anaphylactoid reactions during hemodialysis Clin Nephrol 1994 42 Suppl 1 S44 7
23. Tabei K Effect of apheresis on respiration and hemodynamics Nippon Rinsho 2004 62 41 5
24. Ueda A Nagase S Morito N et al. Anaphylactoid reaction induced by low-molecular-weight heparin in a hemodialysis patient Nephron 2001 87 93 4